Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 3.33% is 27% above its 5-year average of 2.63%, near the high end of its 5-year range (-2.32%–4.30%).
12.79% above its 12-month average of 2.95%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.73%.
OPERATING MARGIN
3.33%
OPERATING MARGIN AVG TTM
2.95%
OPERATING MARGIN AVG 3Y
2.65%
OPERATING MARGIN AVG 5Y
2.63%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+12.79%
CURRENT VS 3Y AVG
+25.43%
CURRENT VS 5Y AVG
+26.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 393 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Operating Margin
3.33%
TTM Avg
2.95%
3Y Avg
2.65%
5Y Avg
2.63%
Market Cap
$12.00B
Operating Margin
18.00%
TTM Avg
16.91%
3Y Avg
21.06%
5Y Avg
16.78%
Market Cap
$12.52B
Operating Margin
-2.39%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$12.89B
Operating Margin
10.15%
TTM Avg
12.77%
3Y Avg
11.89%
5Y Avg
11.41%
Market Cap
$12.95B
Operating Margin
-113.35%
TTM Avg
-190.29%
3Y Avg
-1892.24%
5Y Avg
-2358.01%
Market Cap
$11.36B
Operating Margin
20.73%
TTM Avg
14.55%
3Y Avg
18.31%
5Y Avg
20.93%
Market Cap
$13.19B
Operating Margin
0.77%
TTM Avg
13.08%
3Y Avg
19.11%
5Y Avg
24.45%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 3.33% | 2.95% | 2.65% | 2.63% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 18.00% | 16.91% | 21.06% | 16.78% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 12.45% | 10.35% | 7.09% | 3.40% |
| Baxter International Inc. (BAX)vs › | $12.52B | -2.39% | -1.31% | -6.02% | 0.15% |
| DaVita Inc. (DVA)vs › | $11.47B | 15.06% | 15.52% | 13.94% | 14.32% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 10.15% | 12.77% | 11.89% | 11.41% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -113.35% | -190.29% | -1892.24% | -2358.01% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 20.73% | 14.55% | 18.31% | 20.93% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.77% | 13.08% | 19.11% | 24.45% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $11.12B | 16.56% | 16.77% | 12.22% | 7.02% |
Gross Margin
12.4%
Operating Margin
3.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 3.73% |
| 2026-03-31 | 3.81% |
| 2025-12-31 | 3.04% |
| 2025-09-30 | 2.63% |
| 2025-06-30 | 1.54% |
| 2025-03-31 | 1.76% |
| 2024-12-31 | 2.59% |
| 2024-09-30 | 1.96% |
| 2024-06-30 | 1.59% |
| 2024-03-31 | -0.67% |
| 2023-12-31 | 2.87% |
| 2023-09-30 | -2.32% |
| 2023-06-30 | 3.67% |
| 2023-03-31 | 2.54% |
| 2022-12-31 | 1.20% |
| 2022-09-30 | 1.82% |
| 2022-06-30 | 3.40% |
| 2022-03-31 | 3.40% |
| 2021-12-31 | 3.50% |
| 2021-09-30 | 3.91% |
| 2021-06-30 | 4.30% |
| 2021-03-31 | 3.64% |
| 2020-12-31 | 3.34% |
| 2020-09-30 | 3.67% |
| 2020-06-30 | 2.81% |
| 2020-03-31 | 2.81% |
| 2019-12-31 | 3.60% |
| 2019-09-30 | 3.75% |
| 2019-06-30 | 3.20% |
